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Piglet neonatal diarrhoea is an important issue in modern pig production and is linked to increased mortality and poor growth rates,
affecting long-term pig health, increasing use of medication and cost of production. Saccharomyces cerevisiae var. boulardii (SB) is a
probiotic yeast with documented clinical efﬁcacy in the prevention and treatment of diarrhoeal diseases in humans. The objectives of
the current study were to evaluate the effect of SB on occurrence and severity of neonatal diarrhoea in piglets, mortality and growth
rate. Forty-six litters (606 piglets) were randomly allocated to a control or SB treatment (n = 23 per treatment). Within 24 h of
farrowing, piglets assigned to the SB treatment received a single oral dose of a paste containing 3.3× 109 CFU of SB CNCM I-1079.
Piglets from the control litters received a placebo paste. Piglet weight, mortality and diarrhoea were recorded up to day 7 of age. It was
shown that numbers of diarrhoea days were signiﬁcantly correlated with increased mortality rate and reduced weight gain ( P< 0.05).
SB treatment had no effect on growth or mortality in diarrhoeic litters. However, SB-supplemented litters had signiﬁcantly lower faecal
scores, indicating ﬁrmer faeces ( P< 0.01) and fewer numbers of diarrhoeic days ( P< 0.01) during the 1st week of life. Reduction in the
number of diarrhoeic litters compared with the control group was observed following the probiotic administration ( P< 0.05). These
results highlight the detrimental effects of neonatal diarrhoea on pre-weaning performance and suggest that SB, by reducing diarrhoea
duration and severity, has the potential of improving enteric health in the early stages of life in pigs.
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Implications
Enteric health and growth of the pre-weaning pig inﬂuences
its lifelong production potential, therefore correct manage-
ment of gut health during this time is essential. Considering
the intensifying concerns over emerging antimicrobial resis-
tance and that reduction in antibiotic use is a requirement in
most countries, it is imperative to determine the efﬁcacy of
alternative treatments and prophylaxis such as probiotics.
The current study demonstrates that administering the
probiotic yeast Saccharomyces cerevisiae var. boulardii (SB)
to piglets on the day of farrowing reduces occurrence of
diarrhoea in the 1st week of life; therefore, application of SB
may be used to improve pre-weaning enteric health.
Introduction
Historically, antibiotics have been used in pig medicine to
treat and control bacterial enteric disease. In addition, use
of antibiotic growth promoters is now prohibited in the
European Union and, considering the intensifying concerns
over emerging antimicrobial resistance, antibiotic use, both
frequency and class, has become more tightly controlled in
veterinary medicine (European Commission, 2011; Millet and
Maertens, 2011). Therefore, investment in alternative meth-
ods of controlling enteric disease is essential. Saccharomyces
cerevisiae var. boulardii is a non-pathogenic, non-colonising,
yeast. Several studies have shown that, in humans,
SB is an efﬁcacious and safe probiotic, which has proven
efﬁcacy against some enteric diseases including, but not
limited to, Clostridium difﬁcile-associated disease and
rotavirus diarrhoea (McFarland, 2006; Grandy et al., 2010;
McFarland, 2010). Data on the effect of SB on neonatal
porcine health are limited, possibly because of practical
limitations of administration to individual neonates com-
mercially; however, studies have demonstrated that SB
supplementation improves growth in post-weaning pigs
(Bontempo et al., 2006; Le Bon et al., 2010).
Porcine neonatal diarrhoea is a welfare issue and may
have an economic impact with regards to reduced production† E-mail: Ken.Mellits@nottingham.ac.uk
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and increased mortality. Therefore, the main objective of this
study was to determine if a single oral dose of SB adminis-
tered to neonatal pigs within 24 h of farrowing would reduce
diarrhoea in the 1st week of life.
Material and methods
Experimental design
A randomised controlled trial was undertaken (November–
December 2012) on a farrow-to-wean farm in Sarthe, France,
with a history of neonatal diarrhoea. Commercial parent
sows due to farrow in the same week were paired according
to parity, and a treatment, SB or control, was randomly
allocated (via coin ﬂip, by an independent person) to each
of the pairs. The trial was conducted during 2 consecutive
weeks in identical housing; each treatment involved 23
identical pens (the experimental unit) each containing a
sow with her litter, yielding 299 and 307 piglets for control
and SB treatment, respectively. To test the hypothesis that
reduction of diarrhoea by treatment would lead to an
improvement of health and growth, the number of experi-
mental replicates required was determined using previously
recorded performance data available from this farm (mean
average daily gain (ADG) during the 1st week of life = 0.160
kg, s.d. = 0.041) to demonstrate an improvement of 15%
in ADG by treatment, with a statistical power of 80% and
signiﬁcance of P< 0.05 using the equation:
n¼ ð2σ2ðZβ +Zα=2Þ2Þ=Difference2
where n is the sample size, σ the standard deviation, Zβ the
Z value of power and Zα the Z value of signiﬁcance (Steel
and Torrie, 1996). All trial personnel, including investigators,
were blinded to treatment allocation; blinding was veriﬁed
by anonymous survey. Euthanasia, only where necessary for
welfare reasons, was carried out by manual blunt trauma to the
cranium; this was performed by trained personnel. All animals
in the study were monitored daily by a veterinary surgeon; no
adverse effect of control or SB administration was noted.
Animals were treated according to standard farm practices
unless stated otherwise. Sows were moved to farrowing pens
5 days before their expected farrowing date; pens had a
slatted ﬂoor (1.6 m× 2.5 m), farrowing crate (0.8 m× 2 m)
and an area of solid plastic ﬂooring (triangular: 1.2
m× 0.85 m× 1.5 m) with a heat lamp suspended above
for piglet comfort. Room temperature and humidity was
measured hourly (mean 23.5°C (range 21.5°C to 25°C) and
mean 67% (range 56.5% to 74.5%), respectively). To equi-
librate litter size, neonatal piglets were cross-fostered within
treatment group. On day 0 (day of birth), piglets were
identiﬁed with a numbered colour-coded ear tag, weighed
and administered a 3.3 ml oral dose of paste. Treatment
litters received an individual dose of paste containing
3.3× 109 CFU of dried SB (Levucell®SB, S. cerevisiae CNCM-I
1079; Lallemand Animal Nutrition, Blagnac, France);
control litters received the identical paste with no probiotic
addition (paste constituents: soya oil, cristobalite, icing sugar,
polysorbate 80, ﬂavour). While being handled for paste
administration, piglets also received a 1 ml, intra-muscular
(IM) injection of amoxicillin (150 mg/ml, Vetrimoxin, CEVA
animal health, Libourne, France); within 48 h of birth piglet
teeth were ﬁled, their tails docked via a heated cauterizer
and they received an IM injection of iron (1 ml, 200 mg/ml
Ferro2000; Coophavet, Saint-Herblon, France). At 4 days of
age, piglets were given a 0.7 ml oral dose of the anti-
parasitic product, toltrazuril (50 mg/ml; Baycox, Bayer, Kiel,
Germany) and male piglets were surgically castrated, all in
accordance with routine farm practice. The trial was
approved by the farm’s veterinary consultant, and all pro-
cedures were compliant with French regulations and were
approved by the University of Nottingham ethics committee.
Data collection. Between 0 and 7 days of piglet age, each
pen ﬂoor was examined visually once daily for faecal con-
sistency, by a single investigator blinded for treatment, and a
score allocated to the entire pen using a faecal classiﬁcation
score system. If a score of 5 or more was allocated, the litter
was determined to be diarrhoeic (Lewis and Heaton, 1997;
Pedersen and Toft, 2011). Score 1 is classiﬁed as ‘Separate
hard lumps, like nuts’, score 2 ‘Sausage-shaped, but lumpy’,
score 3 ‘Like a sausage but with cracks on the surface’, score
4 ‘Like a sausage or snake, smooth and soft’, score 5 ‘Soft
blobs with clear cut edges’, score 6 ‘Fluffy pieces with ragged
edges, a mushy stool’ and score 7 ‘Watery, no solid pieces,
entirely liquid’. To monitor production, piglets were weighed
individually at day 0 and day 7; mortality, natural and
euthanasia, was recorded in the same period.
Statistical methods. For all statistical analysis, the litter (pen)
served as the experimental unit (n = 23). For variables that
recorded individual pig measurement (such as weight) the
individuals were clustered for each litter and considered as
random effect. Baseline characteristics of the two treatment
groups were compared before administration of treatment
using general ANOVA; mean and standard error of difference
(s.e.d.) are reported for relevant variables (Table 1). Con-
tinuous data were found to be normally distributed and
analysed using linear mixed models function in GenStat
(14th Edition, GenStat, VSN International). For performance
data (weight, ADG, mortality) and diarrhoea days, the statis-
tical models included treatment as a ﬁxed effect and litter size
at day 0 as the random factor. The relationship between diar-
rhoea days and performances was evaluated using simple lin-
ear regression models. For categorical data: faecal scores and
diarrhoeic status, the effect of treatment was analysed using
χ2 (with Yates’ correction for 2× 2 tables) and χ2 for trend
(GraphPad Software Inc., USA) using primary data.
Results
Effect of SB supplementation on neonatal diarrhoea and
production
After treatment, SB-supplemented litters had signiﬁcantly
fewer days of diarrhoea over the 1st week of life compared to
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controls (P< 0.01; Table 1). This could not be attributed to
sow parity, litter size or average birth weights as these were
not signiﬁcantly different between treatment groups
(Table 1), although increasing sow parity correlated with
number of diarrhoeic days (data not shown). SB litters
also had signiﬁcantly lower faecal scores, indicating ﬁrmer
faeces, during the 1st week of life (Table 2, P< 0.01). Six SB
litters experienced no diarrhoeic events compared with a
single litter in the control group (Table 1). Analysing days
independently, there was a similar number of diarrhoeic
litters per group before treatment (day 0); after treatment,
diarrhoeic litters decreased in the SB group and increased in
the controls (day 3, and over days 1 to 7; P< 0.05, Figure 1).
There was no statistically signiﬁcant effect of SB on growth
or mortality (Table 1). However, as expected, the number of
diarrhoeic days was negatively correlated with ADG and
average weight (both P< 0.01; Figure 2a and b). Moreover,
there was a positive correlation between number of
diarrhoeic days and mortality from day 0 to day 7 (P< 0.05;
Figure 2c).
Discussion
The current study demonstrates that supplementation with
a single dose of SB, within 24 h of birth, reduces both
Table 1 Effect of SB treatment on production and diarrhoea in
neonatal pigs1
Item Control SB s.e.d. P-value
Baseline
Number of litters 23 23 – –
Mean parity 3.65 3.83 0.63 –
Mean litter size 13.00 13.35 0.92 –
Mean initial birth weight (kg) 1.42 1.39 0.05 –
Production
Mean mortality/litter 1.32 0.98 0.63 0.587
Mean ADG over 7 days (kg) 0.158 0.163 0.01 0.744
Diarrhoeal disease
Mean number of diarrhoea days 3.92 2.43 0.53 0.008
Number of diarrhoeic litters 22 17 – 0.101
SB = Saccharomyces cerevisiae var. boulardii; s.e.d. = standard error of dif-
ference; ADG = average daily gain.
1A single individual dose of control paste or SB CNCM-I 1079 (3.3× 109 CFU)
was administered within 24 h of birth to individual piglets. Weight, mortality
and diarrhoea are presented from day 1 to 7. n = 23 litters per treatment.
Table 2 Effect of SB treatment on faecal scores of neonatal pigs1
Score Control SB*
Score 3 10.08% (13) 12.31% (16)
Score 4 24.81% (32) 40.00% (52)
Score 5 41.86% (54) 35.38% (46)
Score 6 19.38% (25) 12.31% (16)
Score 7 3.88% (5) 0
SB = Saccharomyces cerevisiae var. boulardii.
1A single individual dose of control paste or SB CNCM-I 1079 (3.3× 109 CFU)
was administered within 24 h of birth to individual piglets (n = 23 litters per
treatment). Pen faecal scores were recorded daily from day 1 to 7. Score 1 is
classiﬁed as ‘Separate hard lumps, like nuts’, score 2 ‘Sausage-shaped, but
lumpy’, score 3 ‘Like a sausage but with cracks on the surface’, score 4 ‘Like a
sausage or snake, smooth and soft’, score 5 ‘Soft blobs with clear cut edges’,
score 6 ‘Fluffy pieces with ragged edges, a mushy stool’ and score 7 ‘Watery, no
solid pieces, entirely liquid’. Scores 1 and 2 were not detected during the study.
Table shows the percentage of litters (and raw count) of each score for control
and SB treatment between day 1 and 7.
*P< 0.01 (χ 2 for trend on raw counts).
Figure 1 Effect of Saccharomyces cerevisiae var. boulardii (SB) on number
of diarrhoeic litters in the 1st week of life. *P< 0.05. A single individual
dose of SB CNCM-I 1079 (3.3× 109 CFU), or control paste was administered
within 24 h of birth to individual piglets. n = 23 litters per treatment.
Figure 2 Effect of number of days of diarrhoea on average daily weight
gain of piglets from day 0 to 7 (a); average weight at day 7 (b); and
mortality from day 0 to 7 (c), independent of treatment, n = 46. Signiﬁcant
correlations: P< 0.01, P< 0.01 and P< 0.05, respectively. Error bars indicate
standard error of the mean. Coefﬁcients of determination (R2) are indicated.
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occurrence and severity of diarrhoea in piglets over the 1st
week of life. Previous studies, in rats and humans, as well as
our own unpublished data in pigs, have determined SB to be
transient and non-colonising in the gastrointestinal tract
(Blehaut et al., 1989); this is consistent with our ﬁndings that
a signiﬁcant effect of SB was not demonstrated after day 3.
SB has known positive effects on reduction of enteric
pathogens of pigs including Escherichia coli (Lessard et al.,
2008; Collier et al., 2011), and in human studies C. difﬁcile-
associated disease, and rotavirus infection (McFarland, 2006;
Grandy et al., 2010); however, we found no evidence of such
effects (data not shown). Not all diarrhoea is caused by
infectious agents; thus, the signiﬁcant reduction in diarrhoea
in this study, related to SB administration, could be due to
the physiological effects of SB improving osmotic balance.
In rat models, SB administration increases expression of
sodium/glucose co-transporter-1, improving glucose, water
and electrolyte re-absorption in the gut, encouraging ﬂuid
and electrolyte balance (Buts et al., 1999). Studies have also
shown that SB causes an increase in activity of brush border
enzymes, improving nutrient breakdown and absorption
(Buts et al., 1994; Buts and De Keyser, 2006).
Commercial pig production aims to produce highly proliﬁc
sows, as this provides an opportunity to be more proﬁtable,
however, problems of large litters include chilling, inade-
quate colostrum transfer, increased heterogeneity, low birth
weight/non-viability and crushing, as well as high incidence
of neonatal diarrhoea. The issue of increasing litter size has
been previously reviewed, and, as it is unlikely producers will
cease attempting to increase litter size, good management
might negate some issues it brings (Baxter et al., 2013;
Rutherford et al., 2013). Thus, SB could have a role in this
management, as the results of the current study shows it
decreases neonatal diarrhoea.
The current study has shown the potential of SB supple-
mentation by demonstrating the beneﬁt of a single oral dose
on enteric health of the pig. The results show that a single
dose of SB on the day of farrowing signiﬁcantly reduced
number of diarrhoeic days experienced, and promoted lower
faecal scores (ﬁrmer faeces) in the 1st week of life. It has been
suggested that enteric health of the young pig can impact
lifelong gut health (Mahan and Lepine, 1991; McOrist and
Mellits, 2010). Therefore, because of the effect of SB on
diarrhoea, and also the correlation between diarrhoea,
mortality and growth, it may be suggested that continuous
SB administration during the pre-weaning period could have
signiﬁcant effects on production.
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